Reversible Fluoxetine-Induced Hyperthyroidism: A Case Report
- PMID: 26626429
- PMCID: PMC4714632
- DOI: 10.1097/WNF.0000000000000116
Reversible Fluoxetine-Induced Hyperthyroidism: A Case Report
Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) are typically used as antidepressants. Clinically significant SSRI-induced thyroid dysfunction is rare.
Case: We report a case of hyperthyroidism induced by fluoxetine in a female patient with major depressive disorder. Her thyroid profiles indicated hyperthyroidism after a 10-week treatment with fluoxetine and were restored after discontinuation of fluoxetine and administration with venlafaxine. In the first year of follow-up, her thyroid functions as well as her depressive symptoms remained perfectly normal.
Conclusions: This case highlights the necessity of monitoring thyroid profiles during SSRI treatment.
Conflict of interest statement
Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare.
References
-
- Bunevicius R. Thyroid disorders in mental patients. Curr Opin Psychiatry 2009; 22 (4): 391– 395. - PubMed
-
- Greenspan A, Gharabawi G, Kwentus J. Thyroid dysfunction during treatment with atypical antipsychotics. J Clin Psychiatry 2005; 66 (10): 1334– 1335. - PubMed
-
- Mazokopakis EE, Karefilakis CM, Starakis IK. Escitalopram-induced subclinical hypothyroidism. A case report. Hormones (Athens) 2012; 11 (1): 101– 103. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical